Table 4.

Adjusted effect sizes (OR) with 95% CIs of risk factors for COVID-19 ICU admission

Diagnosis (group)	Adjusted OR (95% CI) (all)	Adjusted OR (95% CI) (male)	Adjusted OR (95% CI) (female)
Renal disease	1.76 (1.61–1.92)***	1.58 (1.41–1.77)***	2.04 (1.77–2.36)***
Diabetes without complications	1.57 (1.46–1.69)***	1.39 (1.27–1.52)***	2.00 (1.77–2.26)***
Chronic obstructive pulmonary disease	1.53 (1.41–1.66)***	1.52 (1.37–1.68)***	1.56 (1.36–1.79)***
Diabetes with complications	1.51 (1.35–1.69)***	1.64 (1.43–1.88)***	1.29 (1.06–1.58)**
Rheumatoid disease	1.51 (1.24–1.83)***	1.31 (0.96–1.78)*	1.61 (1.25–2.07)***
Mild liver disease	1.27 (1.15–1.41)***	1.24 (1.09–1.41)***	1.32 (1.10–1.58)***
Congestive heart failure	1.23 (1.12–1.34)***	1.13 (1.00–1.27)**	1.44 (1.24–1.68)***
Moderate or severe liver disease	1.18 (0.87–1.60)	1.17 (0.82–1.68)	1.37 (0.78–2.42)
Peripheral vascular disease	1.14 (1.04–1.25)***	1.12 (1.00–1.25)**	1.27 (1.07–1.50)***
Hemiplegia or paraplegia	1.10 (0.84–1.46)	1.18 (0.85–1.64)	0.97 (0.57–1.64)
Cerebrovascular disease	1.06 (0.97–1.15)	0.99 (0.89–1.10)	1.20 (1.04–1.38)**
Peptic ulcer disease	0.99 (0.80–1.23)	0.94 (0.72–1.23)	1.06 (0.74–1.52)
Acute myocardial infarction	0.99 (0.87–1.12)	0.95 (0.82–1.11)	1.12 (0.88–1.44)
Cancer (any malignancy)	0.97 (0.89–1.06)	0.94 (0.84–1.04)	1.04 (0.89–1.21)
AIDS/HIV	0.81 (0.30–2.16)	0.59 (0.17–2.00)	2.18 (0.35–13.42)
Metastatic solid tumour	0.67 (0.53–0.84)***	0.57 (0.43–0.77)***	0.91 (0.62–1.32)
Dementia	0.56 (0.47–0.67)***	0.50 (0.39–0.65)***	0.63 (0.49–0.81)***
Total number of observations	47,028	29,418	17,610

Authors’ calculation based on [16, 17]

*, **, *** refer to significance at the p < 0.10, p < 0.05, and p < 0.01 level, respectively. Results refer to odds ratios (OR) and 95% confidence intervals (95% CI) obtained from logistic regression; analyses were adjusted for age group, sex and health care region